Report Ocean is delighted to unveil an exhaustive analysis of the Philippines Agricultural Pheromones Market, presenting a detailed exploration of its various dimensions from 2018 to 2032. Our ...

Pheromones are mysterious compounds that can increase attraction for mammals - but as much as the fragrance industry wants us to believe it, that's not yet been proven for humans. There is no ...

Within minutes after David Batts entered the Knox County jail on Jan. 7, Knox County sheriff's officers pepper-sprayed, shocked him with a Taser four times and punched him as they tried to get him ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The flying yellow sand and flowing red mud are a thing of the past. His 9-hectare orchard now makes his family an annual income of over 1 million yuan. This transformation has occurred as a result ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Warmer weather is likely to see them take over apple orchards while strawberries, onions, wheat and oats will become harder to grow Orange groves could replace apple orchards in Britain in the ...

It is hoped the new orchards can provide new community spaces while enhancing the environment Work is under way to plant 20 community orchards as part of a government initiative to celebrate the ...

As a result, Li's expertise in operating drones positioned him as a key competitive advantage for the banana orchard. A growing number of individuals, ranging from drone hobbyists to professionals ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...